• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > Stories

Making Medical History

Home > Stories

Making Medical History

1 Nov 2018

DNDi‘s 15th Anniversary Gala Dinner – 24 October 2018 – NYC

It’s not every day that you have the chance to eliminate one of the world’s most neglected diseases.

It’s also not every day that a group of global health leaders and celebrities in a downtown New York hotel gives a standing ovation to a researcher from the Democratic Republic of Congo (DRC), thousands of miles from the equatorial rain forests where this disease kills. And it’s certainly not every day that the presenter is none other than the “son of Congo,” NBA Hall of Famer and President of the Dikembe Mutombo Foundation, presenting an award designed and donated by one of DRC’s leading sculptors.

But this perfectly sums up last Wednesday evening: the honoree was Dr Victor Kande, the principal Congolese researcher behind the first all-oral treatment for sleeping sickness; the presenter was Dikembe Mutombo; and the award was designed by Professor Alfred Liyolo.

Dr Kande was being honored for Making Medical History – the title of our night. The treatment he helped develop could finally put the elimination of sleeping sickness in our sights, potentially becoming the second disease to ever be eliminated.

A standing ovation for a Congolese doctor

On Wednesday, 24 October, the Drugs for Neglected Diseases initiative (DNDi) organized the Making Medical History Gala at the Bowery Hotel in New York City in celebration of DNDi’s 15-year anniversary. More than 180 friends, supporters, partners, celebrities, and global health influencers attended the Cocktail and Awards Dinner, and another 150-200 joined for a fantastic After Party featuring world-renowned musicians DJ Logic, Falu Shah, Mino Cinélu, Foday Musa Suso, and Constant Boty.

The evening was emceed by doctor and journalist Dr Javid Abdelmonein, and the other presenters and honorees included Sharon Stone, presenting the Visionary Award to Dr Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases at the U.S. National Institutes of Health; Alek Wek, the South Sudanese supermodel, presenting the Founder’s Award to Doctors Without Borders/Médecins Sans Frontières (accepted on behalf of MSF by Dr Joanne Liu, International President); and DNDi’s own Dr Wilfried Mutombo, presenting the Excellence in Journalism Award to HuffPost (accepted by Jo Confino and Paul Josephson).

Dr Javid Abdelmonein

The evening, DNDi’s first-ever Gala, raised almost $500,000 for DNDi’s lifesaving work.

Take a few seconds to browse some images from that memorable night! 

Sharon Stone and Alek Wek
Dikembe Mutombo

Standing ovation for Dr. Kandé for his work in developing better treatments for #sleepingisickness @officialmutombo #makingmedicalhistory pic.twitter.com/ENScKm0aGn

— Drugs for Neglected Diseases initiative (@DNDi) October 25, 2018
The Founder’s Award to Doctors Without Borders/Médecins Sans Frontières was accepted on behalf of MSF by Dr Joanne Liu, International President
Sanofi was the presenting sponsor, and many other partners sponsored the event. Pictured here: Luc Kuykens – Senior Vice President Global Health Programs at Sanofi and Leslie Roessle
The Visionary Award to Dr Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases at the U.S. National Institutes of Health, was presented by American actress Sharon Stone

See the full gallery

Photo credits: Alison Wright & Daniela Kirsch

Funding Sleeping sickness

Read, watch, share

Loading...
Statements
8 May 2025

DNDi’s briefing note for 78th World Health Assembly

Marco Krieger
News
30 Apr 2025

Message on the passing of Dr Marco Aurélio Krieger, Vice-President of Production and Innovation in Health, Fiocruz

Screening activities in village in Guinea
News
25 Apr 2025

Statements from Dr Luis Pizarro and Daisuke Imoto about the Hideyo Noguchi Africa Prize awarded to DNDi

Two man outside of a hospital talking with a nurse
Press releases
24 Apr 2025

Liverpool clinical trial aims to advance life-changing treatment for a deadly parasitic disease

Woman walking in a laboratory
Press releases
23 Apr 2025

DNDi welcomes GHIT support for new project with three Japanese universities to find drug candidates for Chagas disease

Stories
16 Apr 2025

Drug discovery explained: Chagas – How to prove treatments work?

Statements
16 Apr 2025

Statement from the Drugs for Neglected Diseases initiative (DNDi) on the conclusion of WHO Pandemic Agreement negotiations

Press releases
15 Apr 2025

New treatment for cryptococcal meningitis enters Phase II trial as global HIV funding cuts threaten to cause a massive increase in advanced HIV disease

VIEW ALL

Help neglected patients

To date, we have delivered thirteen new treatments, saving millions of lives.

Our goal is to deliver 25 new treatments in our first 25 years. You can help us get there. 

GIVE NOW
Linkedin-in Instagram Twitter Facebook-f Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License